Compare OCGN & CLMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OCGN | CLMB |
|---|---|---|
| Founded | 2013 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 474.8M | 527.7M |
| IPO Year | 2014 | 1996 |
| Metric | OCGN | CLMB |
|---|---|---|
| Price | $1.35 | $27.97 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 2 |
| Target Price | $9.75 | ★ $80.00 |
| AVG Volume (30 Days) | ★ 3.2M | 118.0K |
| Earning Date | 05-05-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 0.60% |
| EPS Growth | N/A | ★ 14.29 |
| EPS | N/A | ★ 0.48 |
| Revenue | N/A | ★ $652,517,000.00 |
| Revenue This Year | N/A | $7.82 |
| Revenue Next Year | $1,718.38 | $5.83 |
| P/E Ratio | ★ N/A | $60.77 |
| Revenue Growth | N/A | ★ 40.14 |
| 52 Week Low | $1.09 | $15.25 |
| 52 Week High | $2.73 | $145.00 |
| Indicator | OCGN | CLMB |
|---|---|---|
| Relative Strength Index (RSI) | 48.94 | 51.39 |
| Support Level | $1.29 | $26.50 |
| Resistance Level | $1.49 | $29.10 |
| Average True Range (ATR) | 0.06 | 1.09 |
| MACD | -0.00 | -0.09 |
| Stochastic Oscillator | 28.57 | 49.65 |
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").
Climb Global Solutions Inc is a cloud-based, value-added IT distribution and solutions company specializing in emerging technologies. It operates across the USA, Canada, United Kingdom, and Europe through multiple business units, including Climb Channel Solutions, Sigma, Grey Matter, Interwork, and TechXtend. The company is organized into two reportable operating segments. The Distribution segment distributes technical software to corporate resellers, value-added resellers (VARs), consultants, and systems integrators under the name Climb Channel Solutions. The Solutions segment is a cloud solutions provider and value-added reseller of software, hardware, and services to customers under the name Grey Matter.